(Q46825630)

English

Risperidone for psychosis of Alzheimer's disease and mixed dementia: results of a double-blind, placebo-controlled trial

scientific article published in December 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16315159

Risperidone for psychosis of Alzheimer's disease and mixed dementia: results of a double-blind, placebo-controlled trial (English)

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16315159

Alzheimer's disease

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

object named as

Henry Brodaty

1 reference

Europe PubMed Central

25 December 2017

author name string

David Ames

2

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16315159

John Snowdon

3

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16315159

Michael Woodward

4

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16315159

Jeff Kirwan

5

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16315159

Roger Clarnette

6

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16315159

Emma Lee

7

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16315159

Andrew Greenspan

8

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16315159

language of work or name

0 references

publication date

1 December 2005

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16315159

International Journal of Geriatric Psychiatry

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16315159

20

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16315159

12

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16315159

1153-1157

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16315159

Agitated behaviors in the elderly. I. A conceptual review

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1409

21 January 2018

A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1409

21 January 2018

Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1409

21 January 2018

Incidence of and risk factors for hallucinations and delusions in patients with probable AD.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1409

21 January 2018

A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1409

7 January 2021

based on heuristic

inferred from DOI database lookup

“Mini-mental state”

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1409

7 January 2021

based on heuristic

inferred from DOI database lookup

Risperidone in the treatment of elderly patients with psychosis of Alzheimer's disease and related dementias

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1409

7 January 2021

based on heuristic

inferred from DOI database lookup

A 2-year follow-up of behavioural and psychological symptoms in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1409

7 January 2021

based on heuristic

inferred from DOI database lookup

Psychosis of Alzheimer's disease and related dementias. Diagnostic criteria for a distinct syndrome.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1409

7 January 2021

based on heuristic

inferred from DOI database lookup

Psychiatric medication and abnormal behavior as predictors of progression in probable Alzheimer disease

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1409

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/GPS.1409

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16315159

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16315159

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46825630&oldid=2133756866"